1Brawn PN,Johnson EH, Speights VO, et al. Incidence, racial differences,and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms. Cancer, 1994,74 : 1607-1611.
2Whitmore WF Jr, Warner JA, Thompson IM Jr. Expectant management of localized prostatic cancer. Cancer, 1991, 67: 1091-1096.
3Peyromaure M, Debre B, Mao K, et al. Management. of prostare cancer in China: a multicenter report of 6 institutions. J Urol,2005,174: 1794-1797.
4Carpentier PJ, Schroder FH. Transrectal ultrasonography in the followup of prostatic carcinoma patients:a new prognostic parameter? J Urol, 1984,131 : 903-905.
5Mazur AW, Thompson IM. Efficacy and morbidity of "channel" TURP. Urology, 1991,38: 526-528.
6Pareek G, Shevchuk M, Armenakas NA, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessl density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol, 2000, 169:20-23.
7Mebust WK, Holtgrewe HL, Cockett ATK, et al. Transurethral prostatectomy: immediate and post-operative complications. A cooperative studies of 13 participating institutions evaluating 3885 patients. J Urol, 1989,141 : 243-248.
8Borboroglu PG, Kane CJ, Ward JF, et al. Immediate and post operative complications of transurethral prostatectomy in the 1990s. J Urol,1999,162:1307-1310.
9Crain DS, Amling CL, Kane CJ. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol, 2004,173 : 668-671.
